PT-141

Description

PT-141, also known as Bremelanotide, is a synthetic research peptide investigated for its
interaction with melanocortin receptor pathways.
Researchers study PT-141 in controlled models involving central signaling, melanocortin
receptor activity, neuroendocrine communication, and behavioral-response pathways.
Primary Research Areas
• Melanocortin receptors
• Central signaling pathways
• Neuroendocrine research
• Receptor activity
• Behavioral-response models
Available Strength: 10 mg
Research Use Only. Not for human or veterinary use.